Article
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutations.
EMBO molecular medicine - 1 Dec 2025
Ballesteros-González Irene, Hernández-Navas Iván, Brehey Oksana, Lechuga Carmen G, Salmón Marina, Scotece Morena, Velasco-Vicente Ricardo, Flores-Gómez Alejandra A, Cebriá Antonio, Simón-Carrasco Lucía, Jiménez Gerardo, Musteanu Monica, Guerra Carmen, Domínguez Orlando, Caleiras Eduardo, Blanco-Aparicio Carmen, Pons Tirso, Ferrer Irene, Paz-Ares Luis, Torres-Ruiz Raul, Rodríguez-Perales Sandra, Barbacid Mariano, Drosten Matthias
Abstract excerpt
KRAS mutations are responsible for a quarter of all lung adenocarcinomas. However, the molecular mechanisms linking these mutations and their frequent secondary dosage amplification to tumor formation are still not fully understood. While ample evidence supports a crucial role for the MAPK pathway in tumor development, the primary effectors targeted by this pathway remain largely unexplored. Here we identify the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
